New Gut Microbiome Research Targets Portal Hypertension Dr David Johnson explores recent data with urolithin A, a gut metabolite that’s shown early promise in studies with portal hypertension.

Aliya Health Group, which owns a group of addiction and behavioral health treatment centers across the United States, has a new leader.